Cross-Sector entity
Every one of those 1 sits in a single category, earnings. Dorman Products is most often covered alongside Celsius Holdings, which appears in 1 of these 1 story. Dorman Products appears in 1 tracked Cross-Sector story from February 26, 2026.
1 verified story tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. Dorman Products is most often covered alongside Celsius Holdings, which appears in 1 of these 1 story. Dorman Products appears in 1 tracked Cross-Sector story from February 26, 2026. The tracked stories average 12 original sources each.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dorman Products. Shared-story counts are live from our verified record — not editorial picks.
Payoneer reported robust Q4 2025 results, driven by double-digit growth in B2B volume and strategic expansion into emerging markets. The broader mid-cap landscape shows a divergence between high-growth consumer brands like Celsius and R&D-heavy biotech firms navigating a complex regulatory environment.
